Bing Mei

Bing Mei discloses dealings in 2 companies, chiefly Kandi Technologies Group, Inc. and Skystar Bio-Pharmaceutical Co. The record holds 7 filings, for trades running from 4 May 2012 to 9 November 2018.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 15 November 2018, reports a share grant in Kandi Technologies Group, Inc. The median gap between a trade and its publication by SEC (Form 4) is 14 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.